R
Revival Research Institute | Southfield, MI
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ABT-494
Upadacitinib
Vancomycin
Ridinilazole
Brazikumab
Donanemab
Parent organization
This site is a part of Revival Research Institute
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approxi...
Enrolling
Alzheimer Disease
Drug: Donanemab
Drug: Placebo
This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...
Active, not recruiting
Ulcerative Colitis (UC)
Drug: Placebo
Drug: Upadacitinib (ABT-494)
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems